Study: Drug development's future lies in partnerships, outsourcing

02/6/2008 | American City Business Journals

Drugmakers are more likely to benefit in the long run from partnerships and outsourcing rather than relying solely on in-house research and development, according to a report by the Tufts Center for the Study of Drug Development. "Moving forward, no company -- big, medium or small pharma, or biotech -- will develop new drugs entirely alone," Kenneth Kaitin, director of the Tufts Center.

View Full Article in:

American City Business Journals

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
ISHN - Chief Compliance Officer
Mountain States Health Alliance
Johnson City, TN
Actuary
Meridian Health Plan
Detroit, MI
President/Chief Executive Officer
MedCost
Winston-Salem, NC
Director, Payer Marketing
Avalere Health
Washington, DC